Suppr超能文献

骨髓受累于淋巴细胞性淋巴瘤和小无裂细胞淋巴瘤:骨髓活检的作用

Bone marrow involvement in lymphoblastic lymphoma and small non-cleaved cell lymphoma: the role of trephine biopsy.

作者信息

Subirà M, Domingo A, Santamaría A, Bordes R, Romagosa V, Soler J

机构信息

Departament d'Hematologia, Hospital de la Santa Creu i San Pau, Barcelona, Spain.

出版信息

Haematologica. 1997 Sep-Oct;82(5):594-5.

PMID:9407729
Abstract

Trephine biopsy (TB) combined with bone marrow aspiration (BMA) is the most common method for evaluating bone marrow (BM) involvement in non-Hodgkin's lymphomas. Nevertheless, the role of TB in high-grade lymphomas remains controversial. We reviewed the results of 42 consecutive BMAs and TBs performed simultaneously in 29 patients with lymphoblastic lymphoma (LL) and small, non-cleaved cell lymphoma (SNCL). In LL, 8M involvement was documented in 35.4% of the cases by BMA and 22.5% of the cases by TB. In SNCL it was documented in 45.4% of the cases by BMA and 36.3% by TB. There were no statistically significant differences (p > 0.05) in the rates of BM involvement found by TB or BMA in the two types of lymphoma, although BMA appeared to be more sensitive than TB. These observations suggest that routine TB may not be necessary in assessing BM involvement in patients with LL and SNCL.

摘要

环钻活检(TB)联合骨髓穿刺(BMA)是评估非霍奇金淋巴瘤骨髓(BM)受累情况最常用的方法。然而,TB在高级别淋巴瘤中的作用仍存在争议。我们回顾了对29例淋巴母细胞淋巴瘤(LL)和小无裂细胞淋巴瘤(SNCL)患者同时进行的42次连续BMA和TB的结果。在LL中,BMA检测到35.4%的病例存在骨髓受累,TB检测到22.5%的病例存在骨髓受累。在SNCL中,BMA检测到45.4%的病例存在骨髓受累,TB检测到36.3%的病例存在骨髓受累。两种类型淋巴瘤中,TB或BMA检测到的骨髓受累率无统计学显著差异(p>0.05),尽管BMA似乎比TB更敏感。这些观察结果表明,在评估LL和SNCL患者的骨髓受累情况时,常规TB可能并非必要。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验